CDH1 and hearing loss disorder: Finally, the PPI networks identified in this study, particularly those involving RUNX2, TGFB2, and CDH1, may serve as the foundation for novel therapeutic approaches aimed at restoring auditory function in patients who have already experienced radiotherapy-induced hearing impairment.